Insilico Medicine earns second consecutive Prix Galien USA “Best Start-Up” Nomination

Insilico Medicine included in MSCI Global Small Cap Indexes, gaining capital market endorsement in core strengths

Insilico Medicine introduces biological age into virtual cell research: launches virtual aging cell webpage and previews multi-agent driven VAC generation platform - EurekAlert!

Insilico Medicine nominates ISM0900, a potent, AI-driven, oral Lp(a) inhibitor, as PCC for management of cardiovascular risks - EurekAlert!